Zealand Pharma and B
Zealand Pharma and Boehringer Ingelheim enter into a licence and collaboration agreement to advance novel compounds to treat Type-2 diabetes and obesity
June 16, 2011 01:49 ET | Zealand Pharma A/S
Copenhagen, Denmark and Ingelheim, Germany, 2011-06-16 07:49 CEST (GLOBE NEWSWIRE) -- Company Announcement No. 10/2011     Zealand Pharma and Boehringer Ingelheim enter into a...
Zealand Pharma og Bo
Zealand Pharma og Boehringer Ingelheim indgår licens- og samarbejdsaftale om udvikling af nye lægemiddelkandidater til behandling af type 2-diabetes og fedme
June 16, 2011 01:49 ET | Zealand Pharma A/S
København, Danmark og Ingelheim, Tyskland, 2011-06-16 07:49 CEST (GLOBE NEWSWIRE) -- Selskabsmeddelelse Nr. 10/2011     Zealand Pharma og Boehringer Ingelheim indgår licens- og...
Additional positive
Additional positive Phase III results with Lyxumia® (lixisenatide) for the treatment of Type 2 diabetes
May 31, 2011 01:27 ET | Zealand Pharma A/S
Copenhagen, 2011-05-31 07:27 CEST (GLOBE NEWSWIRE) -- Company Announcement No. 09/2011       Additional positive Phase III results with Lyxumia® (lixisenatide) for the...
Lyxumia® (lixisenati
Lyxumia® (lixisenatide) til behandling af type 2-diabetes opnår yderligere positive fase III resultater
May 31, 2011 01:27 ET | Zealand Pharma A/S
København, 2011-05-31 07:27 CEST (GLOBE NEWSWIRE) -- Selskabsmeddelelse Nr. 09/2011     Lyxumia® (lixisenatide) til behandling af type 2-diabetes opnår yderligere positive...
Zealand Pharma to pr
Zealand Pharma to present at UBS Global Specialty Pharmaceuticals Conference 2011
May 23, 2011 04:02 ET | Zealand Pharma A/S
Copenhagen, 2011-05-23 10:02 CEST (GLOBE NEWSWIRE) -- Investor News No. 08/2011   Zealand Pharma to present at UBS Global Specialty Pharmaceuticals Conference...
Zealand Pharma præse
Zealand Pharma præsenterer på UBS Global Specialty Pharmaceuticals konferencen 2011
May 23, 2011 04:02 ET | Zealand Pharma A/S
København, 2011-05-23 10:02 CEST (GLOBE NEWSWIRE) -- Investornyheder Nr. 08/2011       Zealand Pharma præsenterer på UBS Global Specialty Pharmaceuticals...
Zealand Pharma A/S -
Zealand Pharma A/S - Q1 2011 interim report (un-audited)
May 12, 2011 07:27 ET | Zealand Pharma A/S
Copenhagen, 2011-05-12 13:27 CEST (GLOBE NEWSWIRE) -- Company Announcement No. 08/2011   Zealand Pharma A/S – Q1 2011 interim report (un-audited)...
Delårsrapport for 1.
Delårsrapport for 1. kvartal 2011 (ikke revideret)
May 12, 2011 07:27 ET | Zealand Pharma A/S
København, 2011-05-12 13:27 CEST (GLOBE NEWSWIRE) -- Selskabsmeddelelse Nr. 08/2011   Zealand Pharma A/S  Delårsrapport for 1. kvartal 2011 (ikke...
Zealand Pharma - Not
Zealand Pharma - Notice of Q1 2011 interim report and conference call
May 06, 2011 07:31 ET | Zealand Pharma A/S
    Investor News No. 07/2011     Zealand Pharma Notice of Q1 2011 interim report and conference call   Copenhagen, 6 May 2011 – Zealand Pharma (NASDAQ...
Zealand Pharma - Dat
Zealand Pharma - Dato for delårsrapport for 1. kvartal 2011 og telefonkonference
May 06, 2011 07:31 ET | Zealand Pharma A/S
  Investornyheder Nr. 07/2011      Zealand Pharma Dato for delårsrapport for 1. kvartal 2011 og telefonkonference   København, 6. maj 2011 – Zealand Pharma...